Top Markets
Coin of the day
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd

017180
주식 순위 #28117
MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise,... MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Korea and into global markets. The company offers an extensive array of prescription drugs, addressing a broad spectrum of medical conditions. This range includes treatments for musculoskeletal issues like osteoarthritis, inflammation, rheumatoid arthritis, and muscle relaxation, alongside anti-infectives (antibiotics and antifungals), respiratory aids, and gastrointestinal therapeutics. Cardiovascular health is targeted with circulation agents, anti-hypertensive drugs, and antidiabetic medications. Furthermore, their specialized pharmacotherapy solutions cover narcotics, anesthetics, central nervous system agents, female hormone products, osteoporosis treatments, urogenital medications, adrenocortical hormones, oncology drugs, dermal fillers, and anti-obesity agents. Beyond prescription items, MYUNGMOON Pharm also supplies a diverse selection of over-the-counter (OTC) remedies. These encompass medications for nausea, genitourinary concerns, gum disease, liver support, parasitic infections, constipation, oral ailments, diarrhea, and general digestive health. The OTC portfolio further includes cold and flu treatments, calcium supplements, nasal sprays, multi-vitamins, eye nutrition products, eye drops, blood circulation enhancers, and topical preparations such as external skin treatments and localized pain relievers. In addition to its pharmaceutical lines, the firm markets health supplements, quasi-pharmaceuticals, and blended juice beverages. Established in 1983, MYUNGMOON Pharm Co., Ltd. maintains its primary corporate office in Seoul, South Korea.
주가
$0.84154769
시가총액
$28.13M
변동 (1일)
1.76%
변동 (1년)
-30.02%
국가
KR
거래 MYUNGMOON Pharm co.,Ltd (017180)

카테고리

B의 시가 총액을 가진 017180의 가격
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
017180
$0.84154769
의 시가총액 MYUNGMOON Pharm co.,Ltd(017180)
시가총액: $28.13M
August 2026 기준으로 MYUNGMOON Pharm co.,Ltd의 시가총액은 $28.13M입니다. 이는 당사 데이터에 따르면 MYUNGMOON Pharm co.,Ltd이 세계에서 28117th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2008부터 2026까지 MYUNGMOON Pharm co.,Ltd의 시가총액 기록
017180 가장 인기있는 상위 5 가지 stocks과 비교하여
017180의 가격 자산 b b의 시장 결과
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$158,564 $28.13M
$5.301T +18,841,803.07%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$138,612 $28.13M
$4.634T +16,470,955.99%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$123,928 $28.13M
$4.143T +14,726,100.07%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$107,368 $28.13M
$3.589T +12,758,303.68%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$85,459.22 $28.13M
$2.857T +10,154,906.58%